These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 17468644)
41. A randomized trial to determine the tolerability and immunogenicity of a quadrivalent meningococcal glycoconjugate vaccine in healthy adolescents. Jackson LA; Jacobson RM; Reisinger KS; Anemona A; Danzig LE; Dull PM Pediatr Infect Dis J; 2009 Feb; 28(2):86-91. PubMed ID: 19116603 [TBL] [Abstract][Full Text] [Related]
42. ACOG Committee Opinion number 314, September 2005. Meningococcal vaccination for adolescents. American College of Obstetricians and Gynecologists Obstet Gynecol; 2005 Sep; 106(3):667-9. PubMed ID: 16135612 [TBL] [Abstract][Full Text] [Related]
43. Use of Serogroup B Meningococcal Vaccines in Adolescents and Young Adults: Recommendations of the Advisory Committee on Immunization Practices, 2015. MacNeil JR; Rubin L; Folaranmi T; Ortega-Sanchez IR; Patel M; Martin SW MMWR Morb Mortal Wkly Rep; 2015 Oct; 64(41):1171-6. PubMed ID: 26492381 [TBL] [Abstract][Full Text] [Related]
44. National, state, and local area vaccination coverage among adolescents aged 13-17 years--United States, 2008. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2009 Sep; 58(36):997-1001. PubMed ID: 19763075 [TBL] [Abstract][Full Text] [Related]
45. Preventing meningococcal infection in college students. Harrison LH Clin Infect Dis; 2000 Apr; 30(4):648-51. PubMed ID: 10770724 [TBL] [Abstract][Full Text] [Related]
46. Quadrivalent meningococcal ACYW-135 glycoconjugate vaccine for broader protection from infancy. Pace D Expert Rev Vaccines; 2009 May; 8(5):529-42. PubMed ID: 19397410 [TBL] [Abstract][Full Text] [Related]
47. Meningococcal vaccine: New product, new recommendations. Campos-Outcalt D J Fam Pract; 2005 Apr; 54(4):324-6. PubMed ID: 15833222 [TBL] [Abstract][Full Text] [Related]
48. Revised recommendations of the Advisory Committee on Immunization Practices to Vaccinate all Persons Aged 11-18 Years with Meningococcal Conjugate Vaccine. Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices MMWR Morb Mortal Wkly Rep; 2007 Aug; 56(31):794-5. PubMed ID: 17694617 [No Abstract] [Full Text] [Related]
49. Uptake of meningococcal conjugate vaccine among adolescents in large managed care organizations, United States, 2005: demand, supply and seasonality. Lorick SA; Fishbein D; Weintraub E; Wortley PM; Lee GM; Zhou F; Davis R BMC Infect Dis; 2009 Nov; 9():175. PubMed ID: 19887009 [TBL] [Abstract][Full Text] [Related]
51. Immunogenicity and immune memory of a nonadjuvanted quadrivalent meningococcal glycoconjugate vaccine in infants. Perrett KP; Snape MD; Ford KJ; John TM; Yu LM; Langley JM; McNeil S; Dull PM; Ceddia F; Anemona A; Halperin SA; Dobson S; Pollard AJ Pediatr Infect Dis J; 2009 Mar; 28(3):186-93. PubMed ID: 19209097 [TBL] [Abstract][Full Text] [Related]
52. An evaluation of the immunogenicity and safety of a new trivalent meningococcal polysaccharide vaccine. Chandramohan D; Hodgson A; Coleman P; Baiden R; Asante K; Awine E; Owusu-Agyei S; Boutriau D; Nelson CB; Greenwood B Vaccine; 2007 Sep; 25 Suppl 1():A83-91. PubMed ID: 17521782 [TBL] [Abstract][Full Text] [Related]
53. Epidemiologic investigation and targeted vaccination initiative in response to an outbreak of meningococcal disease among illicit drug users in Brooklyn, New York. Weiss D; Stern EJ; Zimmerman C; Bregman B; Yeung A; Das D; Dentinger CM; Marx MA; Kornblum J; Lee L; Halse TA; Mayer LW; Hatcher CP; Theodore MJ; Schmink S; Harcourt BH; Zucker JR; Layton M; Clark TA; Clin Infect Dis; 2009 Apr; 48(7):894-901. PubMed ID: 19231975 [TBL] [Abstract][Full Text] [Related]
54. An Advisory Committee Statement (ACS). Statement on recommended use of meningococcal vaccines. National Advisory Committee on Immunisation (NACI) Can Commun Dis Rep; 2001 Oct; 27():2-36. PubMed ID: 11706686 [No Abstract] [Full Text] [Related]
55. The preteen visit: an opportunity for prevention. Campos-Outcalt D J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541 [TBL] [Abstract][Full Text] [Related]
56. An update on the invasive meningococcal disease and meningococcal vaccine conjugate recommendations. An Advisory Committee Statement (ACS). National Advisory Committee on Immunization (NACI) Can Commun Dis Rep; 2009 Apr; 35(ACS-3):1-40. PubMed ID: 19400026 [No Abstract] [Full Text] [Related]
57. Updated recommendation from the Advisory Committee on Immunization Practices (ACIP) for use of 7-valent pneumococcal conjugate vaccine (PCV7) in children aged 24-59 months who are not completely vaccinated. ; MMWR Morb Mortal Wkly Rep; 2008 Apr; 57(13):343-4. PubMed ID: 18385642 [TBL] [Abstract][Full Text] [Related]
58. Meningococcal vaccine for infants? Campos-Outcalt D J Fam Pract; 2012 Aug; 61(8):482-4. PubMed ID: 22871657 [TBL] [Abstract][Full Text] [Related]
59. Protecting the world against meningitis: new recommendations from the CDC's advisory committee on immunization practices. Cyrus SS; J Am Osteopath Assoc; 2011 Oct; 111(10 Suppl 6):S17-9. PubMed ID: 22086889 [TBL] [Abstract][Full Text] [Related]
60. Meningococcal group C disease in Greece during 1993-2006: the impact of an unofficial single-dose vaccination scheme adopted by most paediatricians. Kafetzis DA; Stamboulidis KN; Tzanakaki G; Kourea Kremastinou J; Skevaki CL; Konstantopoulos A; Tsolia M Clin Microbiol Infect; 2007 May; 13(5):550-2. PubMed ID: 17378929 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]